TA
KRRO icon

TRB Advisors’s Korro Bio KRRO Stock Holding History

TRB Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-946
Closed -$471K – 9
2021
Q2 		$471K Hold
946
– – 0.11% 12
2021
Q1 		$449K Hold
946
– – 0.17% 10
2020
Q4 		$1.67M Hold
946
– – 0.75% 12
2020
Q3 		$908K Buy
+946
New +$1.02M 0.36% 12

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRB Advisors's KRRO Position: Q3 2021 in Review

TRB Advisors sold out of Korro Bio (KRRO) in Q3 2021, closing a stake of 946 shares — an estimated $471K sold.

TRB Advisors first reported a position in KRRO in Q3 2020 and held it in 4 quarters. The position peaked at $1.67M in Q4 2020. 88 funds tracked by Wall St. Rank hold KRRO as of Q3 2021.

  • TRB Advisors reported no remaining Korro Bio position as of Q3 2021 after selling out during the quarter.
  • TRB Advisors sold 946 Korro Bio shares in Q3 2021, an estimated $471K.
  • TRB Advisors first reported a position in Korro Bio in Q3 2020 and held it in 4 quarters.
  • TRB Advisors's Korro Bio position peaked at $1.67M in Q4 2020.
  • 88 funds tracked by Wall St. Rank held Korro Bio as of Q3 2021.

Based on TRB Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.